
    
      This single dose, randomized, two-period, two-treatment, two sequence crossover study was
      conducted to compare the relative bioavailability of ciprofloxacin 1000 mg ER tablets of Dr.
      Reddy's and CIPROÂ® XR 1000 mg of Bayer Pharmaceuticals Corporation under non-fasting
      conditions.
    
  